WHO recommends long-acting cabotegravir for HIV prevention: New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention. WHO...
The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization...
HIV treatments - where we are today and what's next: Despite the ambitious 2020 goals set by UNAIDS 90-90-90 not being reached, innovative HIV treatments – from preventative...